Beat the rise! Delivery fees are going up soon. INFO

Close Notification

Your cart does not contain any items

Prediction of Bioequivalence of Generic Drug Products Via in-vitro Tests

Venkateswarlu V

$77.95   $66.63

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
BSP Books Private Limited
01 May 2026
Prediction of Bioequivalence of Generic Drug Products via In-Vitro Tests presents a comprehensive and systematic approach to one of the most critical challenges in pharmaceutical development-predicting bioequivalence outcomes. Rooted in the author's extensive academic teaching and industry experience, including contributions at Dr. Reddy's Laboratories and the establishment of a Centre of Excellence in Biostudies, this book bridges the gap between theory and real-world application.

The book guides readers from fundamental concepts of drug absorption and bioavailability to advanced methodologies such as biorelevant dissolution testing, IVIVC, reverse engineering of reference products, and designaround strategies. It provides practical insights and case studies that enable scientists to minimize failures in bioequivalence studies, reduce evelopment timelines, and meet regulatory expectations with confidence.

Written in a clear and lucid manner, this book is an essential resource for students, formulation scientists, biostudy professionals, and regulatory experts seeking a deeper understanding of predictive approaches in generic drug development.
By:  
Imprint:   BSP Books Private Limited
ISBN:   9789347311260
ISBN 10:   934731126X
Pages:   270
Publication Date:  
Audience:   General/trade ,  ELT Advanced
Format:   Paperback
Publisher's Status:   Active

Dr. V. Venkateswarlu is a pharmaceutical scientist, US post-doctoral researcher, and former faculty member at the University College of Pharmaceutical Sciences, Kakatiya University. He has guided 12 Ph.D.scholars and published around 80 National and International research papers with 15 patents. He is the author of Fundamentals of Biopharmaceutics and Pharmacokinetics.He currently serves as Managing Director of Neuheit Pharma Technologies Pvt. Ltd., Hyderabad, focusing on complex generics, differentiated formulations, and bioequivalence studies for global markets. Earlier, he served as Vice President (R&D) at Dr. Reddy's Laboratories, leading QBD based pharmaceutical development.

See Also